Correlation Between Scpharmaceuticals and Lumos Pharma
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Lumos Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Lumos Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Lumos Pharma, you can compare the effects of market volatilities on Scpharmaceuticals and Lumos Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Lumos Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Lumos Pharma.
Diversification Opportunities for Scpharmaceuticals and Lumos Pharma
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Scpharmaceuticals and Lumos is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Lumos Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lumos Pharma and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Lumos Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lumos Pharma has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Lumos Pharma go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Lumos Pharma
If you would invest 434.00 in Lumos Pharma on November 7, 2024 and sell it today you would earn a total of 0.00 from holding Lumos Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
Scpharmaceuticals vs. Lumos Pharma
Performance |
| Timeline |
| Scpharmaceuticals |
| Lumos Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Scpharmaceuticals and Lumos Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Lumos Pharma
The main advantage of trading using opposite Scpharmaceuticals and Lumos Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Lumos Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lumos Pharma will offset losses from the drop in Lumos Pharma's long position.| Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |